Condition: Autoimmunity, Inflammation · Sponsor: Novartis Pharmaceuticals
The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment with secukinumab, and are unable to obtain the marketed secukinumab formulation.
This description comes directly from the study's public registry record.
Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com
Novartis Pharmaceuticals · +41613241111
Always discuss trial participation with your own doctor first.
| Providence Medical Foundation | Fullerton, California, United States | Completed |
| Purushotham Akther and Roshan Kotha MD Inc | La Mesa, California, United States | Completed |
| Precn Comprehensive Clnl Rsch Solns | San Leandro, California, United States | Completed |
| Orrin Troum MD and Medical Associates | Santa Monica, California, United States | Completed |
| Inland Rheumatology Clinical Trials INC | Upland, California, United States | Completed |
| Medvin Clinical Research | Van Nuys, California, United States | Completed |
| Center for Rheumatology Research | West Hills, California, United States | Completed |
| Denver Arthritis Clinic | Denver, Colorado, United States | Completed |
| Rheumatology Associates of South Florida | Boca Raton, Florida, United States | Recruiting |
| Homestead Assoc In Research Inc | Homestead, Florida, United States | Completed |
| IRIS Research and Development | Plantation, Florida, United States | Completed |
| Conquest Research | Winter Park, Florida, United States | Completed |
+ 155 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04638647